Latest filing published 20 May 2014 for Eloxx Pharmaceuticals, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Warren John Isabelle: trading record in brief
Warren John Isabelle discloses dealings in Eloxx Pharmaceuticals, Inc. to SEC (Form 4). Over a trading history stretching from 29 July 2009 to 16 May 2014, the count stands at 8 filings.
Every open-market trade on record is a purchase: 4 purchases worth €1,420, and no sale. The amount is not disclosed for 3 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 3 share grants.
On 20 May 2014 came the latest disclosure, a share grant in Eloxx Pharmaceuticals, Inc. The clock since the last published purchase (23 February 2010) now reads 6,103 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Warren John Isabelle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares0Common StockSEC:0001144204-14-032377:0
- 3,470 shares@ US$0.3673Common StockSEC:0001179110-10-009412:0
- 1,487 shares@ US$0.5135Common StockSEC:0001179110-10-009412:1
- 77,840 shares@ US$0.83Common StockSEC:0001179110-10-009412:2
- 16,745 shares0Common StockSEC:0001179110-10-003457:0Canonical exit: 20 May 2010 (T+90)
- 2,000 shares0Common Stock WarrantsSEC:0001179110-09-011380:1Canonical exit: 27 Oct 2009 (T+90)
- 2,028 shares0Common Stock WarrantsSEC:0001179110-09-011380:2Canonical exit: 27 Oct 2009 (T+90)
7 of 7 declarations
